The relentless rise of resistance?

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 306-310

  Wise, Richard ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Antibacterials; Health; Resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; AVERMECTIN DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; ERYTHROMYCIN; GENERIC DRUG; IMIPENEM; MACROLIDE; NEW DRUG; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANIMAL HEALTH; ANIMAL WELFARE; ANTIBIOTIC RESISTANCE; ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; DRUG INDUSTRY; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; DRUG USE; GOVERNMENT; HEALTH HAZARD; HUMAN; INFECTION CONTROL; MEDICAL PROFESSION; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; PUBLIC HEALTH SERVICE; SOCIOECONOMICS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIOLOGY; POPULATION SURVEILLANCE;

EID: 4444282440     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh340     Document Type: Article

References (34)

1. Denning, D. W., Baily, G. G. & Hood, S. V. (1997). Azole resistance in Candida. European Journal of Clinical Microbiology and Infectious Diseases 16, 261-80.
2. Larder, B. A., Darby, G. & Richman, D. D. (1989). HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243, 1731-4.
3. Wise, R. (2003). Antimicrobial resistance: the microbes struggle for survival. Equine Veterinary Journal 35, 530-1.
4. Darwin, C. (1859). On the Origin of Species by Means of Natural Selection. Murray, London.
5. Jones, J. S. (1999). Almost Like a Whale - The Origin of Species Updated, pp. 95-9. Doubleday, London.
6. Blazquez, J. (2003). Hypermutation as a factor contributing to the acquisition of antibacterial resistance. Clinical Infectious Diseases 37, 1201-9.
7. Friedland, I. R. & McCracken, G. H. (1994). Management of infections caused by antibiotic resistant Streptococcus pneumoniae. New England Journal of Medicine 331, 337-82.
8. Ho, P. L., Yung, R. W. H., Tsang, D. N. C. et al. (2001). Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. Journal of Antimicrobial Chemotherapy 48, 659-65.
9. Fraise, A. P., Mitchell, K., O'Brien, S. J. et al. (1997). Methicillin-resistant Staphylococcus aureus (MRSA) in nursing homes in a major UK city: an anonymised point prevalence study. Epidemiology and Infection 118, 1-5.
10. Vandenesch, F., Naimi, T., Enright, M. C. et al. (2003). Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine Leukocidin genes: worldwide emergence. Emerging Infectious Diseases 9, 978-84.
11. Baird, D. (2002). Extended spectrum β-lactamase producing coliforms - a new problem in a new hospital. SCIEH Weekly Report 36, 130-1.
12. Fenton, K. A., Ison, C., Johnson, A. P. et al. (2003). Ciprofloxacin resistance in Neisseria gonorrhoea in England and Wales in 2002. Lancet 361, 1867-9.
13. House of Lords. (1998). Seventh Report of the House of Lords Select Committee on Science and Technology. Stationery Office, London.
14. MacGowan, A. P., Bowker, K. E., Bennett, P. M. et al. (1998). Surveillance of antimicrobial resistance. Lancet 352, 1783.
15. Working Party Report. (2001). Antimicrobial susceptibility testing. Journal of Antimicrobial Chemotherapy 48, Suppl. 1.
16. Pillay, D. & Zambon, M. (1998). Antiviral drug resistance. British Medical Journal 317, 660-2.
17. Harbarth, S., Harris, A. D., Carmeli, Y. et al. (2001). Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in Gram negative bacilli. Clinical Infectious Diseases 33, 1462-8.
18. House of Lords. (2003). Fourth Report of the House of Lords Select Committee on Science and Technology. Stationery Office, London.
19. Kaplan, S. L., Mason, E. O., Wald, E. R. et al. (2004). Decrease in invasive pneumococcal infections in children amongst childrens hospitals in the United States after the introduction of the 7-valent, pneumococcal conjugate vaccine. Paediatrics 113, 443-9.
20. Department of Health. (2003). Winning Ways. Department of Health, London.
21. Projan, S. J. (2003). Why is BigPharma getting out of antibacterial drug discovery? Current Opinion in Microbiology 6, 427-30.
22. White, R. J. (2003). Are the rules different for Biotech companies? In Program and Abstracts of the Forty-third Interscience Conference on Antimicrobial Agents and Chemotherapy, 2003. Abstract, p. 519. American Society for Microbiology, Washington, DC, USA.
23. Middleton, B. (2004). Uphill battle for UK Biotechs. New Scientist 181, 52-3.
24. Kollef, M. H. (2001). Optimizing antibiotic therapy in the intensive care unit setting. Critical Care 5, 189-94.
25. Loeffler, J. M., Garbino, J., Lew, D. et al. (2003). Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scandinavian Journal of Infectious Diseases 35, 843-50.
26. Burke, J. P. (1999). Antibiotic resistance - squeezing the balloon? Journal of the American Medical Association 280, 1270-1.
27. Kristinsson, K. G. (1997). Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microbial Drug Resistance 3, 117-23.
28. Seppala, H., Klaukka, T., Vuopio-Varkila, J. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. New England Journal of Medicine 337, 441-6.
29. Austin, D. J. & Anderson, R. M. (1999). Studies of antibiotic resistance within patients, hospitals and the community using simple mathematical models. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 354, 721-38.
30. Austin, D. J., Kristinsson, K. G. & Anderson, R. M. (1999). The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proceedings of the National Academy of Sciences, USA 96, 800-1.
31. ESAC Management Team. Consumption of antibiotics in ambulatory care in Europe. [Online.] http://www.ua.ac.be/esac
32. PACT Centre. Antibacterial drugs. http://www.ppa.org.uk/news/pact-092002.htm
33. Kendall, H. E., Holdsworth, S. & Sharland, M. (2004). GP antibiotic prescribing for children in England from 1993-2002 has fallen by 50%. In 8th Spring Meeting Royal College of Paediatrics and Child Health, York, UK, 2004.
34. European Antimicrobial Resistance Surveillance System. http://www.earss.rivm.nl